EUVIMEDEUVIMED entdecken
Crossref

Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes

Yuyue Zuo iD, Yueqi Zhang, Zilu Qu, Bei Wang, Yan Zhao, Lei Dai, Liuqing Chen, Li Xu

The Journal of Dermatology · 2024

DOI: 10.1111/1346-8138.17366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Yuyue Zuo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Psoriasis, Keratinocytes, Cell Proliferation, Imiquimod. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Wuhan Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive proliferation of keratinocytes is a crucial pathological risk feature of psoriasis. Focal adhesion kinase (FAK) is a non‐receptor protein that primarily regulates cell proliferation and migration. However, the expression and regulatory mechanism of FAK in psoriasis remains unclear. This study aimed to investigate the regulation of FAK in psoriasis and examined the potential impact of FAK inhibitor on psoriasis. A small molecular selective FAK inhibitor, defactinib, was used to evaluate the effect of FAK on psoriasis in in vitro and in vivo functional assays. In our experiments, imiquimod (IMQ)‐induced psoriasis mice and human keratinocytes cells were used to study the potential roles and mechanisms of FAK in psoriasis. FAK phosphorylation has been weakly detected in normal intact skin and is markedly elevated upon IMQ treatment. By reducing FAK phosphorylation (p‐FAK), defactinib treatment could attenuate psoriasiform inflammation and epidermal hyperplasia in IMQ‐treated mice compared with IMQ‐induced mice treated with the vehicle. In in vitro studies, resiquimod (R848) increased (p‐FAK) and promoted cell proliferation in human keratinocytes cells, while defactinib reversed this effect. Mechanistically, defactinib can alleviate the proliferation via JNK/YB1 pathway in vitro and in vivo. Defactinib significantly attenuates psoriasiform inflammation and epidermal hyperproliferation through the inhibition of the FAK‐mediated axis. The downregulation of phosphorylated FAK then suppressed the activation of JNK/YB1 protein signaling pathway in psoriasis. Our work highlights targeting FAK as a potentially effective strategy for the treatment of psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisKeratinocytesCell ProliferationImiquimodFocal Adhesion Kinase 1Disease Models, AnimalAnimalsHumansPhosphorylationMiceSkinSignal TransductionMaleBenzamidesPyrazinesSulfonamides

Stichwörter der Autor:innen

JNKYB1defactinibfocal adhesion kinasephosphorylationpsoriasis

Substanzen

ImiquimodFocal Adhesion Kinase 1defactinibPTK2 protein, humanPtk2 protein, mouseBenzamidesPyrazinesSulfonamides

Autor:innen und Institutionen

  • Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, Hubei, China.
  • Hubei Province & Key Laboratory of Skin Infection and Immunity, Wuhan, Hubei, China.
  • Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, Hubei, China.

ORCID-Profile: Yuyue Zuo

Förderung

  • Wuhan Science and Technology Bureau

Zitieren

APA

Zuo, Y., Zhang, Y., Qu, Z., Wang, B., Zhao, Y., Dai, L., Chen, L., & Xu, L. (2024). Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17366

Vancouver

Zuo Y, Zhang Y, Qu Z, Wang B, Zhao Y, Dai L, et al. Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17366

BibTeX
@article{Zuo2024,
  author = {Zuo, Yuyue and Zhang, Yueqi and Qu, Zilu and Wang, Bei and Zhao, Yan and Dai, Lei and Chen, Liuqing and Xu, Li},
  title = {Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes},
  journal = {The Journal of Dermatology},
  year = {2024},
  doi = {10.1111/1346-8138.17366}
}
Kostenlos starten →